
    
      This is a Randomized, Open-Label, Two Period Crossover, Chronic Dosing, 1-Week, Pilot Study
      to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Inhalation Aerosol
      Administered with a Spacer Compared with Symbicort® Turbuhaler® in Subjects with Severe to
      Very Severe Chronic Obstructive Pulmonary Disease and Low Peak Inspiratory Flow to assess
      lung function
    
  